130 related articles for article (PubMed ID: 3462303)
41. HLA-DQ rather than HLA-DR region might be involved in dominant nonsusceptibility to diabetes.
Sterkers G; Zeliszewski D; Chaussée AM; Deschamps I; Font MP; Freidel C; Hors J; Betuel H; Dausset J; Levy JP
Proc Natl Acad Sci U S A; 1988 Sep; 85(17):6473-7. PubMed ID: 2901099
[TBL] [Abstract][Full Text] [Related]
42. Restriction fragment length polymorphism of HLA and non-HLA genes in DR3/4 heterozygous Danish insulin-dependent diabetic patients and healthy individuals: reassessment of the influence of alpha DX and insulin-linked polymorphic loci, and new splits of DQw3 haplotypes.
Zerbib A; Mølvig J; Thomsen M; Coppin H; Cambon-Thomsen A; Sommer E; Nerup J; De Preval C
Dis Markers; 1989; 7(1):27-41. PubMed ID: 2565778
[TBL] [Abstract][Full Text] [Related]
43. A systematic study of HLA class II-beta DNA restriction fragments in insulin-dependent diabetes mellitus.
Cohen-Haguenauer O; Robbins E; Massart C; Busson M; Deschamps I; Hors J; Lalouel JM; Dausset J; Cohen D
Proc Natl Acad Sci U S A; 1985 May; 82(10):3335-9. PubMed ID: 2987920
[TBL] [Abstract][Full Text] [Related]
44. DNA polymorphism of the class II genes in DR4 cells.
So A; Bodmer J
Dis Markers; 1986 Jun; 4(1-2):165-72. PubMed ID: 2898313
[TBL] [Abstract][Full Text] [Related]
45. HLA DQ beta 3.2 identifies subtypes of DR4+ haplotypes permissive for IDDM.
Robinson DM; Holbeck S; Palmer J; Nepom GT
Genet Epidemiol; 1989; 6(1):149-54. PubMed ID: 2567255
[TBL] [Abstract][Full Text] [Related]
46. Association of HLA class II alleles and CTLA-4 polymorphism with type 1 diabetes.
Ei Wafai RJ; Chmaisse HN; Makki RF; Fakhoury H
Saudi J Kidney Dis Transpl; 2011 Mar; 22(2):273-81. PubMed ID: 21422625
[TBL] [Abstract][Full Text] [Related]
47. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
[TBL] [Abstract][Full Text] [Related]
48. Frequency and associations of HLA class II TaqI allogenotypes in the Northern Ireland population.
Cullen CG; Middleton D; Savage DA
Hum Immunol; 1990 Oct; 29(2):92-102. PubMed ID: 1979073
[TBL] [Abstract][Full Text] [Related]
49. Insulin-dependent diabetes mellitus: HLA-DR and -DQ genotyping in three ethnic groups.
Kohonen-Corish MR; Serjeantson SW; Lee HK; Zimmet P
Dis Markers; 1987 Sep; 5(3):153-64. PubMed ID: 2901933
[TBL] [Abstract][Full Text] [Related]
50. Class II HLA-DC beta-chain DNA restriction fragments differentiate among HLA-DR2 individuals in insulin-dependent diabetes and multiple sclerosis.
Cohen D; Cohen O; Marcadet A; Massart C; Lathrop M; Deschamps I; Hors J; Schuller E; Dausset J
Proc Natl Acad Sci U S A; 1984 Mar; 81(6):1774-8. PubMed ID: 6324215
[TBL] [Abstract][Full Text] [Related]
51. HLA-DR and -DQ DNA genotyping in insulin-dependent diabetes patients in South India.
Serjeantson SW; Ranford PR; Kirk RL; Kohonen-Corish MR; Mohan V; Ramachandran A; Snehalatha C; Viswanathan M
Dis Markers; 1987 Jun; 5(2):101-8. PubMed ID: 2901931
[TBL] [Abstract][Full Text] [Related]
52. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus.
Todd JA; Bell JI; McDevitt HO
Nature; 1987 Oct 15-21; 329(6140):599-604. PubMed ID: 3309680
[TBL] [Abstract][Full Text] [Related]
53. Analysis of HLA-DQ molecules with a monoclonal antibody detecting a DQ polymorphism absent from DQW1 homozygous cells.
Radka SF; Stewart SJ; Smith SA
Hum Immunol; 1985 Nov; 14(3):206-19. PubMed ID: 3863810
[TBL] [Abstract][Full Text] [Related]
54. Allelic polymorphism and transassociation of molecules encoded by the HLA-DQ subregion.
Giles RC; DeMars R; Chang CC; Capra JD
Proc Natl Acad Sci U S A; 1985 Mar; 82(6):1776-80. PubMed ID: 3856859
[TBL] [Abstract][Full Text] [Related]
55. Molecular polymorphism of various HLA-D subregions and rheumatoid arthritis.
Tonnelle C; Milili M; Gebuhrer L; Roudier J; Betuel H; Roux H; Fougereau M
Ann Inst Pasteur Immunol; 1988; 139(1):41-53. PubMed ID: 2896003
[TBL] [Abstract][Full Text] [Related]
56. Molecular analysis of HLA-DR beta and DQ beta polymorphism in Chinese with rheumatoid arthritis.
Molkentin J; Gregersen PK; Lin X; Zhu N; Wang Y; Wang Y; Chen S; Chen S; Baxter-Lowe LA; Silver J
Ann Rheum Dis; 1993 Aug; 52(8):610-2. PubMed ID: 8215626
[TBL] [Abstract][Full Text] [Related]
57. Identification of two cis-encoded HLA-DQ molecules that carry distinct alloantigenic specificities.
Johnson JP; Wank R
J Exp Med; 1984 Nov; 160(5):1350-9. PubMed ID: 6208309
[TBL] [Abstract][Full Text] [Related]
58. Correlation between an HLA-DQ alpha length polymorphism of messenger RNA and serologically defined specificities (DQw1, DRw53, DR3+5).
Loiseau P; Lehn P; Dautry F; Lepage V; Colombani J; Cohen D; Dausset J; Degos L
Immunogenetics; 1986; 23(2):111-4. PubMed ID: 3007342
[TBL] [Abstract][Full Text] [Related]
59. Immunochemistry of the HLA class II molecules isolated from a mouse cell transfected with DQ alpha and beta genes from a DR4 haplotype.
Tanigaki N; Tosi R; Strominger JL; Cooper J
Immunogenetics; 1987; 26(1-2):40-7. PubMed ID: 3610253
[TBL] [Abstract][Full Text] [Related]
60. Radioimmunoassay typing gives a more precise definition of the HLA association of type 1 (insulin-dependent) diabetes.
Tosi R; Vela M; Adorno D; Longo A; Papola F; Maccarone D; Centis D; Tanigaki N; Raponi MP; Candela A
Diabetologia; 1986 Jul; 29(7):430-3. PubMed ID: 3462067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
